The QMN Weekly Bulletin

FDA Inspectors Increasing Scrutiny of Supplier Controls: Official

Dec. 9, 2011
A A
Amid continuing concern that breaks in the global supply chain will beget another heparin crisis, FDA inspectors are upping scrutiny of drug and device manufacturers’ supplier controls to ensure they are sufficiently robust and clearly articulated in scientific terms, agency officials say.
Drug GMP Report